Suggesting that Ankrd2 might have a role in supporting cancer progression, our findings demonstrated that it was not the overexpression rather the absence of Ankrd2 that had remarkable effects on the pathophysiology of OS cells [14]. The gene discussed is ANKRD2; the disease is cancer.